
Liminatus Pharma, Inc. — Investor Relations & Filings
Liminatus Pharma, Inc. is a pre-clinical-stage biopharmaceutical company focused on developing novel, immune-modulating cancer therapies. The company specializes in immuno-oncology and is pioneering the development of a second-generation CD47-blockade antibody. This therapeutic approach is designed to utilize the patient's immune system to target and destroy cancer cells. Its lead clinical candidate, IBA101, is a humanized anti-CD47 antibody being advanced toward clinical trials for the treatment of various cancers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-06-03 | English | |
| FORM 8-K | 2026-05-27 | English | |
| FORM 8-K | 2026-05-20 | English | |
| 10-Q | 2026-05-15 | English | |
| 10-K - Liminatus Pharma, Inc. (0001971387) (Filer) | 2026-03-31 | English | |
| 8-K - LIMINATUS PHARMA, INC. (0001971387) (Filer) | 2026-03-04 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 47948572 | 424B3 | 2026-06-03 | English | ||
| 47845366 | FORM 8-K | 2026-05-27 | English | ||
| 46693288 | FORM 8-K | 2026-05-20 | English | ||
| 46362206 | 10-Q | 2026-05-15 | English | ||
| 33122863 | 10-K - Liminatus Pharma, Inc. (0001971387) (Filer) | 2026-03-31 | English | ||
| 32900806 | 8-K - LIMINATUS PHARMA, INC. (0001971387) (Filer) | 2026-03-04 | English | ||
| 32267708 | 8-K Filing | 2026-02-18 | English | ||
| 32267649 | 424B4 Filing | 2026-02-18 | English | ||
| 32267778 | S-1 Filing | 2026-02-11 | English | ||
| 32267630 | 8-K Filing | 2026-02-09 | English | ||
| 13651327 | FORM 8-K | 2026-01-26 | English | ||
|
2025
4 filings
| |||||
| 13651348 | FORM 8-K | 2025-11-25 | English | ||
| 13651425 | 10-Q | 2025-11-14 | English | ||
| 13651432 | 10-Q | 2025-10-04 | English | ||
| 13651428 | FORM 8-K | 2025-08-25 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CS Medica A/S
Develops and manufactures OTC medical devices and cosmetics…
|
CSMED | DK | Manufacturing |
|
CSPC Innovation Pharmaceutical Co.,Ltd.
Global supplier of caffeine, pharmaceutical ingredients, an…
|
300765 | CN | Manufacturing |
|
CSPC Pharmaceutical Group Limited
R&D, manufacturing, and sale of innovative finished and bul…
|
1093 | HK | Manufacturing |
|
CStone Pharmaceuticals
Innovation-driven biopharma focused on R&D and commercializ…
|
2616 | KY | Manufacturing |
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
Liminatus Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34636/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34636 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34636 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34636 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34636}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Liminatus Pharma, Inc. (id: 34636)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.